BRS2-3-7 - Phosphatidylcholine Formation

(PEMT methylation and Kennedy-pathway phosphatidylcholine synthesis)

1. Mission, Objective & Biological Context

Mission

Maintain phosphatidylcholine formation through PEMT methylation and the choline-based Kennedy pathway.

Intervention Dominance: Diet-Supported — Dietary Requirements

Conditional animal evidence concerns folate restriction and methyl-derived PC enrichment; it does not establish absolute PEMT flux, benefit above adequacy or cognitive benefit. Dietary prominence is supported within the studied animal context; it is not a head-to-head ranking against lifestyle or optimisation, a human intake target, or evidence of benefit from extra intake.

Overview

Cells form phosphatidylcholine through distinct routes: hepatic PEMT methylates phosphatidylethanolamine using SAMe, while the Kennedy pathway combines choline-derived phosphocholine with CTP and then diacylglycerol. Uridine can contribute upstream to nucleotide supply. These routes support membrane phospholipid provision; precursor availability does not establish that extra intake increases human membrane synthesis or improves cognition. [19] [20] [1]

• Benefits: PC formation supplies a major membrane phospholipid. PEMT/choline-route loss in mice demonstrates the importance of maintaining hepatic PC provision; the new uridine evidence measures precursor formation, not a clinical benefit. [1] [19]
• Implementation Notes: Choline and phosphatidylcholine can supply the existing methyl-donor provision route. Uridine adds a supported nucleotide-precursor route, with no established ordinary-food dose or human PC-flux benefit. [20] [21]
• Biological Relevance: Only the PEMT branch directly couples methylation to membrane chemistry in the parent FM. Kennedy synthesis is a parallel PC-forming route; brain DHA delivery and incorporation remain separate downstream jobs. [1] [19]

2. Primary Biological Effects

Phosphatidylcholine formation through distinct PEMT and Kennedy routes; S-adenosylhomocysteine production confined to PEMT methyl transfer. [1] [19]

3. Levers

Dietary methyl-resource provision is supported; no intake optimisation protocol is established.

4. Mechanistic Basis

Summary

PC formation has two distinct routes. Hepatic PEMT uses SAMe to methylate phosphatidylethanolamine. The Kennedy pathway builds PC using choline, CTP and diacylglycerol; uridine can contribute to its nucleotide supply. Neither route alone establishes brain DHA uptake or cognitive benefit. [1] [19]

4.1 Scientific Findings (8)

Scientific Findings and their source assessments are available in Evidence & Audit.

5. BRS Pathways and Connections

5.1 BRS Pathways

BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation ↓ BRS2-FM3-PM7 — Phosphatidylcholine Formation ↓ BRS1-FM3-PM7 — Neuronal Membrane DHA Incorporation

5.2 Cross-BRS Mechanism Relationships

Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.

• BRS1-FM3-PM7 — Neuronal Membrane DHA Incorporation — Hepatic methylation produces phosphatidylcholine from phosphatidylethanolamine. Later blood–brain transport of DHA and its uptake into neuronal membranes are a downstream delivery step, not this methyl transfer.

5.3 Local BRS Mechanism Relationships

Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.

• BRS2-FM1-PM2 — Betaine/BHMT Remethylation — Choline-derived betaine contributes methyl groups through homocysteine remethylation to methionine and subsequent SAMe synthesis. This upstream chain supports methyl-group provision to PEMT (SF7 — Dietary choline forms supply methyl groups to the PEMT route).

• BRS2-FM1-PM3 - SAMe Synthesis — Methionine adenosyltransferase produces the S-adenosylmethionine consumed in each phosphatidylethanolamine methylation. That is upstream methyl-donor supply, not the methylation reaction itself.

7. Phenome Connections

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

Cognitive Clarity — modulatesOpen Page →→

Focus / Attention Stability — modulatesOpen Page →→

8. References

• [1] Vance (2014) — Physiological Roles of Phosphatidylethanolamine N-methyltransferase
• [2] Arellanes et al. (2020) — Brain Delivery of Supplemental DHA
• [3] Liu et al. (2014) — Phospholipid versus Triglyceride DHA Accretion in Neonatal Piglets
• [4] Oulhaj et al. (2016) — Omega-3 Status and B Vitamins in Mild Cognitive Impairment
• [5] Millichap and Yee (2012) — Diet Factor in ADHD
• [6] Derbyshire and Maes (2023) — Choline in Neurodevelopmental Disorders
• [7] Shields et al. (2003) — Membrane Topography of Human PEMT
• [8] Shields et al. (2003) — SAMe-Binding Site of Human PEMT
• [9] Ridgway and Vance (1988) — Kinetic Mechanism of Hepatic PEMT
• [10] Böckmann et al. (2023) — Human Tracing of Dietary Choline Forms
• [11] Chew et al. (2011) — Folate Intake and Choline Metabolism
• [12] Kharbanda et al. (2007) — Betaine and PEMT Production
• [13] Sugiyama et al. (1998) — Dietary Methionine and PE Methylation
• [14] Shimada et al. (2003) — Methionine and Hepatic Phospholipids
• [15] Cano et al. (2011) — MAT1A Loss and PEMT Activity
• [16] Sugiyama et al. (1995) — Eritadenine and Hepatic Phospholipid Metabolism
• [17] Robinson et al. (2016) — Methionine Partitioning under Methyl-Donor Restriction
• [18] Asiriwardhana et al. (2025) — Dietary Methionine and Transmethylated Products
• [19] Ulus et al. (2006) — Cytidine and Uridine Increase Striatal CDP-Choline Levels Without Decreasing Acetylcholine Synthesis or Release
• [20] Cansev et al. (2005) — Oral uridine-5-monophosphate (UMP) increases brain CDP-choline levels in gerbils
• [21] Agarwal et al. (2010) — Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults
• [22] Wurtman et al. (2006) — Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally
• [23] Murray et al. (2016) — Human MAT catalytic steps

Therapeutic Area evidence

Condition interpretations below reference canonical evidence records; study facts are not rewritten on this mechanism page.

• ADHD
  • brs2-fm3-pm7-ec000137 — Dietary patterns rich in fibre, folate, and omega-3 fatty acids associated with reduced ADHD symptoms Open this evidence
  • brs2-fm3-pm7-ec000138 — Choline implicated across neurodevelopmental disorders including ADHD, linking remethylation and phosphatidylcholine pathways Open this evidence